Sihuan Pharmaceutical Holdings Group Ltd. — AGM Information 2020

May 14, 2020

==> picture [76 x 100] intentionally omitted <==

Sihuan Pharmaceutical Holdings Group Ltd. 四環醫藥控股集團有限公司

(incorporated in Bermuda with limited liability)

(Stock Code: 0460)

FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING

(Block capitals) of being (see Note 1) shares of HK$0.01 each in the capital of

I/We (Name) (Address)

the holder(s) of shares of HK$0.01 each in the capital of Sihuan Pharmaceutical Holdings Group Ltd. (the ‘‘Company’’) hereby appoint (Name) of (Address) or failing him/her (Name) of (Address) or failing him/her, the chairman of the meeting[(see][Note][2)] as my/our proxy to attend and vote for me/us and on my/our behalf at the annual general meeting of the Company to be held at Conference Room Vision 4+5, 4th Floor, Hilton Shenzhou Futian, Tower B, Great China International Finance Centre, 1003 Shennan Road, Futian, Shenzhen, the People’s Republic of China, on Monday, 15 June 2020 at 10:00 a.m., and at any adjournment thereof or on any resolution or motion which is proposed thereat. My/Our proxy is authorized and instructed to vote as indicated[(see][Note][3)] in respect of the undermentioned resolutions:

==> picture [483 x 240] intentionally omitted <==

----- Start of picture text ----- Ordinary Resolutions [(see] [Note] [3)] For [(see] [Note] [3)] Against [(see] [Note] [3)]1. To receive and adopt the audited consolidated financial statements of the Company and thereports of the directors of the Company (the ‘‘Directors’’) and auditors of the Company (the‘‘Auditors’’) for the year ended 31 December 2019.2. To approve the declaration and payment of a final cash dividend for the year ended 31December 2019.3. (a) To re-elect the following retiring Directors:(i) Kim Jin Ha as a non-executive Director(ii) Tsang Wah Kwong as an independent non-executive Director(iii) Patrick Sun, who has served as an independent non-executive Director for morethan nine years, as an independent non-executive Director(b) To authorize the board of Directors (the ‘‘Board’’) to fix the remuneration of theDirectors.4. To re-appoint Ernst & Young as Auditors and authorize the Board to fix their remuneration.5. (A) To give a general mandate to the Directors to allot, issue and deal with additionalshares not exceeding 20 per cent of the number of issued shares of the Company.(B) To give a general mandate to the Directors to repurchase shares not exceeding 10 percent of the number of issued shares of the Company.(C) To extend the authority given to the Directors pursuant to ordinary resolution no. 5(A)to issue shares by adding to the number of issued shares of the Company the numberof shares repurchased under ordinary resolution no. 5(B).Dated this day of , 2020 Signature(s): (see Note 5)----- End of picture text -----

Notes:

1. Please insert the number of shares registered in your name(s); if no number is inserted, this form of proxy will be deemed to relate to all the shares in the capital of the Company registered in your name(s).

2. A shareholder may appoint more than one proxy of his/her own choice. If such an appointment is made, strike out the words ‘‘the chairman of the meeting’’, and insert the name(s) of the person(s) appointed as proxy in space provided. Any alteration made to this form of proxy must be initialed by the person who signs it.

3. IMPORTANT: IF YOU WISH TO VOTE FOR ANY RESOLUTION, PLEASE TICK THE BOX MARKED ‘‘For’’. IF YOU WISH TO VOTE AGAINST ANY RESOLUTION, PLEASE TICK THE BOX MARKED ‘‘Against’’. Failure to tick a box will entitle your proxy to cast your vote at his/her discretion. Your proxy will also be entitled to vote at his/her discretion on any amendment of a resolution properly put to the meeting.

4. If the appointor is a corporation, this form must be under common seal or under the hand of an officer, attorney, or other person duly authorized on that behalf. 5. In the case of joint holders, the signature of any one holder will be sufficient but the names of all the joint holders should be stated. Where there are joint holders of any share of the Company, any one of such joint holders may vote at the meeting, either in person or by proxy, in respect of such share as if he/she were solely entitled thereto, but if more than one of such joint holders be present at the meeting, the vote of the senior who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint holders, and for this purpose seniority shall be determined as that one of the said persons so present whose name stands first on the register of members in respect of such share shall alone be entitled to vote in respect thereof.

5. InvestorTo be valid,Servicesthis formLimited,of proxyat Levelmust54,beHopewellcompleted,Centre,signed183andQueendeposited’s Roadat theEast,HongHongKongKong,branchtogethersharewithregistrarthe powerand transferof attorneyofficeor ofotherthe authorityCompany,(ifTricorany) under which it is signed (or a certified copy thereof), not less than 48 hours before the time fixed for holding the meeting or any adjournment thereof. The completion and return of the form of proxy shall not preclude shareholders of the Company from attending and voting in person at the above meeting (or any adjourned meeting thereof) if they so wish.

6. A proxy need not be a shareholder of the Company.